Physician profile
Abiram Bala
NPI 1457715963
$14,152.74
in general payments reported to CMS, 2019-2025
12 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,179 · 2020: $2,479 · 2021: $5,204 · 2022: $3,227 · 2023: $725 · 2024: $167 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Education: $97.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.22 |
| Education | $97.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $6,997.69 | 2019-2021 | |
| Depuy Synthes Products, INC. | $2,534.89 | 2021 | |
| Encore Medical, LP | $1,645.30 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,311.64 | 2022-2024 | Persona, Rosa, Avenir |
| Stryker Corporation | $878.62 | 2021-2025 | Mako, Profyle, Gamma |
| Smith+Nephew, INC. | $261.75 | 2022-2023 | Real Intelligence, Or3o Dual Mobility, Polarstem |
| Orthalign INC | $168.83 | 2022 | |
| Depuy Synthes Sales INC. | $109.93 | 2022 | |
| Si-Bone, INC. | $88.69 | 2021 | |
| Conformis, INC. | $78.78 | 2022 | |
| Nuvasive, INC. | $60.42 | 2020 | |
| Medical Device Business Services, INC. | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abiram Bala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.